News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Onaitis Matthew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/02/2018 |
4
| Onaitis Matthew (Gnrl Counsel, CFO & Secretary) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 72,000 options to buy
@ $4, valued at
$288k
|
|
| 09/19/2017 |
4
| Onaitis Matthew (Gnrl Counsel, CFO & Secretary) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Exercised 25,000 restricted stock units
@ $0 |
|
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2016 |
4
| Onaitis Matthew (Gnrl Counsel, CFO & Secretary) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $10.45, valued at
$1.1M
|
|
| 01/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/09/2015 |
4
| Onaitis Matthew (General Counsel and Secretary) has filed a Form 4 on Ignyta, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 44,160 options to buy
@ $6.58, valued at
$290.6k
|
|
| 09/13/2013 |
4
| Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 100,000 options to buy
@ $7.67, valued at
$767k
|
|
| 06/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2013 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Pernix Sleep, Inc.|
Txns:
| Disposed/sold 47,098 shares
@ $0 |
|
| 11/20/2012 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 10/02/2012 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 15,716 shares
@ $0 |
|
| 07/03/2012 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Granted 15,992 shares
@ $0 |
|
| 01/04/2012 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $0.4767, valued at
$4.3k
|
|
| 12/03/2010 |
4
| Onaitis Matthew (SVP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 8,468 shares
@ $2.6835, valued at
$22.7k
|
|
| 04/05/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2010 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 5,580 shares
@ $3.94, valued at
$22k
Sold 2,627 shares
@ $7, valued at
$18.4k
Sold 15,000 shares
@ $6.5921, valued at
$98.9k
Sold 14,454 shares
@ $9, valued at
$130.1k
Exercised 4,166 options to buy
@ $1.23, valued at
$5.1k
Exercised 17,945 options to buy
@ $1.23, valued at
$22.1k
Exercised 2,066 options to buy
@ $1.23, valued at
$2.5k
Exercised 1,111 options to buy
@ $1.23, valued at
$1.4k
|
|
| 03/03/2010 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 30,000 shares
@ $4.0155, valued at
$120.5k
Exercised 9,066 options to buy
@ $1.23, valued at
$11.2k
Exercised 20,934 options to buy
@ $1.23, valued at
$25.7k
|
|
| 02/09/2010 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 60,000 shares
@ $3.0251, valued at
$181.5k
Exercised 25,000 options to buy
@ $1.23, valued at
$30.8k
Exercised 12,400 options to buy
@ $1.23, valued at
$15.3k
Exercised 6,666 options to buy
@ $1.23, valued at
$8.2k
Exercised 15,934 options to buy
@ $1.23, valued at
$19.6k
|
|
| 01/05/2010 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $1.07, valued at
$5.4k
|
|
| 07/20/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 06/10/2009 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 02/19/2009 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
| 12/02/2008 |
4
| Onaitis Matthew (VP, General Counsel) has filed a Form 4 on Somaxon Pharmaceuticals, Inc. |
|
|